Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Lanlin Zhang"'
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Dendritic cell- (DC-) based vaccination has emerged as a promising antitumour immunotherapy. However, overcoming immune tolerance and immunosuppression in the tumour microenvironment (TME) is still a great challenge. Recent studies have shown that Ro
Externí odkaz:
https://doaj.org/article/89b8fcf9590f438988fb5e55a96d5c0c
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-11 (2019)
Abstract Background Lung cancer has become the most common cancer type and caused the most cancer deaths. Lung adenocarcinoma (LUAD) is one of the major type of lung cancer. This study aimed to establish a signature based on immune related genes that
Externí odkaz:
https://doaj.org/article/dff1950e67de407fb6656b9dc24227ae
Autor:
ZHANG Chen, YU Lanlin, ZHANG Wendong, CHENG Yu, MI Xiaoyu, WANG Siqi, WANG Longfeng, JIANG Yun
Publikováno v:
Shipin Kexue, Vol 44, Iss 10, Pp 114-122 (2023)
In this study, the survival of the main serotypes O157:H7 and O26:H11 of Shiga toxin-producing Escherichia coli (STEC) inoculated in fermented sausage during processing was investigated, and the changes of virulence gene expression in the bacteria an
Externí odkaz:
https://doaj.org/article/0671443cae0d494a8baec79079982af4
Publikováno v:
J Thorac Dis
Background Lymph node dissection is an important part of lung cancer surgery. Preoperational evaluation of lymph node metastases decides which dissection pattern should be chosen. The present study aimed to develop a nomogram to predict lymph node me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b26c07581475cabe051a1a081e5c049
https://doi.org/10.21037/jtd-20-601
https://doi.org/10.21037/jtd-20-601
Publikováno v:
Journal of Cellular Biochemistry. 121:3208-3220
Considering the existence of immune-desert in tumor microenvironment, the clinical efficacy of immunotherapy for lung adenocarcinoma is limited. This study aims to investigate the ability of transcription factors in regulating tumor immune microenvir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf72dc11c0cd2f4694bcd720bbae4ea1
https://doi.org/10.1002/jcb.29587
https://doi.org/10.1002/jcb.29587
Publikováno v:
Journal of immunology research. 2022
Dendritic cell- (DC-) based vaccination has emerged as a promising antitumour immunotherapy. However, overcoming immune tolerance and immunosuppression in the tumour microenvironment (TME) is still a great challenge. Recent studies have shown that Ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eee6e740612381278071c5c7daf50c2a
https://pubmed.ncbi.nlm.nih.gov/35155685
https://pubmed.ncbi.nlm.nih.gov/35155685
Publikováno v:
Current Problems in Cancer. 43:411-420
Thymic carcinomas (TCs) and thymic neuroendocrine tumors (TNETs) are aggressive cancers with poor survival outcome and limited investigation. This study is to investigate clinicopathologic features on TC and TNET patients' prognosis of a large cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c547169b59445add4afb94957efa9763
https://doi.org/10.1016/j.currproblcancer.2019.03.004
https://doi.org/10.1016/j.currproblcancer.2019.03.004
Publikováno v:
Journal of cellular biochemistryREFERENCES. 121(5-6)
Considering the existence of immune-desert in tumor microenvironment, the clinical efficacy of immunotherapy for lung adenocarcinoma is limited. This study aims to investigate the ability of transcription factors in regulating tumor immune microenvir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bbc5d6ce1181b1103c4dbc703add6d3f
https://pubmed.ncbi.nlm.nih.gov/31898342
https://pubmed.ncbi.nlm.nih.gov/31898342
Autor:
Shenglin Huang, Si Sun, Lanlin Zhang, Hui Yu, Qifeng Wang, Xianghua Wu, Xun Ye, Jialei Wang, Xingjiang Hu, Zhihuang Hu, Jianhua Chang
Publikováno v:
Journal of cancer research and clinical oncology. 145(9)
Recent research has classified lung adenocarcinoma patients with KRAS mutation into three subtypes by co-occurring genetic events in TP53 (KP subgroup), STK11/LKB1 (KL subgroup) and CDKN2A/B inactivation plus TTF-1 low expression (KC subgroup). The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9793ad9291cae6f5991f11e53b22f18
https://pubmed.ncbi.nlm.nih.gov/31428934
https://pubmed.ncbi.nlm.nih.gov/31428934
Additional file 1: Table S1. The gene lists of the 10 gene groups.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c56fd7cfb71783c27998e277ee6931f
